Sandoz Group AG (OTCMKTS:SDZNY – Get Free Report) shares reached a new 52-week high during trading on Wednesday . The stock traded as high as $48.66 and last traded at $48.61, with a volume of 114786 shares changing hands. The stock had previously closed at $46.70.
Wall Street Analyst Weigh In
Separately, BNP Paribas cut shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 2nd.
Check Out Our Latest Research Report on Sandoz Group
Sandoz Group Trading Up 4.1 %
About Sandoz Group
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
See Also
- Five stocks we like better than Sandoz Group
- 3 Warren Buffett Stocks to Buy Now
- 3 Must-Have ETFs Set to Dominate This Quarter
- Pros And Cons Of Monthly Dividend Stocks
- Seeking Stability? These 3 Stocks Offer Strong Potential
- Business Services Stocks Investing
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
